Publications

 

Fillipone, C., Marianneau, P., Murri, S., Mollard, N., Avsic-Zupane, T., Chinikar, S., Desprès, P., Gessain, A., Berthet, N., and Tordo, N. (2012). High density DNA resequencing microarrays for the diagnosis/discovery of highly pathogenic viruses: application to Crimean Congo hemorrhagic fever virus outbreaks. Clin.Microbiol. Infect. in press

Brandler S, Marianneau P, Loth P, Lacôte S, Combredet C, Frenkiel MP, Desprès P, Contamin H, Tangy F. (2012). Measles vaccine expressing the secreted form of west nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of west nile virus infection. J.Infect.Dis. 206: 212-9

Bouraï M, Lucas-Hourani M, Gad HH, Drosten C, Jacob Y, Tafforeau L, Cassonnet P, Jones LM, Andrè P, Kümmerer BM, Lotteau, V, Desprès P, Tangy F, Vidalain, PO. (2012). An interactome map of virus infection network. J. Virol. 86: 3121-34

Kudelko M, Brault JB, Kwok K., Li MY, Pardigon N, Malik Peiris JS, Bruzzone R, Desprès P, Nal B, Wang PG. (2012). Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses. J.Biol.Chem. 287: 767-77

 

Desprès P (2011). Sur le risque de propagation de la dengue et du chikungunya en Europe du Sud. Les Feuillets de Biologie (in French) Vol.III n°304, 39-51

Brault JB, Kudelko M, Vidalain PO, Tangy F, Desprès P, Pardigon N. (2011). The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication. Virology 417:369-78

Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Desprès P, Wang CI, Nardin A. (2011). Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J Immunol.186:3258-64

Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Desprès P, Briant L, Yssel H, Missé D. (2011). Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol. 11:1664-73

Simon-Chazottes D, Frenkiel MP, Montagutelli X, Guénet JL, Desprès P, Panthier JJ. (2011). Transgenic expression of full-length 2',5'-oligoadenylate synthetase 1b confers to BALB/c mice resistance against West Nile virus-induced encephalitis. Virology 417:147-53.

Grandadam M, Caro V, Plumet S, Thiberge JM, Souarès Y, Failloux AB, Tolou HJ, Budelot M, Cosserat D, Leparc-Goffart I, Desprès P. (2011). Chikungunya virus, southeastern France. Emerg Infect Dis. 17:910-3.

Kristiansen H, Gad HH, Eskildsen-Larsen S, Desprès P, Hartmann R. (2011). The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res. 31:41-7. Review.

 

Murray KO, Mertens E, Desprès P. (2010). West Nile virus and its emergence in the United States of America. Vet Res. 41:67. Review.

La Ruche G, Souarès Y, Armengaud A, Peloux-Petiot F, Delaunay P, Desprès P, Lenglet A, Jourdain F, Leparc-Goffart I, Charlet F, Ollier L, Mantey K, Mollet T, Fournier JP, Torrents R, Leitmeyer K, Hilairet P, Zeller H, Van Bortel W, Dejour-Salamanca D, Grandadam M, Gastellu-Etchegorry M (2010). First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010 S15:19676.

Brandler S, Ruffie C, Najburg V, Frenkiel MP, Bedouelle H, Desprès P, Tangy F. (2010). Pediatric measles vaccines expressing a dengue tetravalent antigen elicit neutralizing antibodies against all four dengue viruses. Vaccine 28:6730-9

Mertens E, Kajaste-Rudnitski A, Torres S, Funk A, Frenkiel MP, Iteman I, Khromykh AA, Desprès P. (2010). Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2',5'-oligoadenylate synthetase 1b. Virology 399:176-85

 

Bellier B, Huret C, Miyalou M, Desjardins D, Frenkiel MP, Desprès P, Tangy F, Dalba C, Klatzmann D. (2009). DNA vaccines expressing retrovirus-like particles are efficient immunogens to induce neutralizing antibodies. Vaccine 27:5772-80. 

Hershkovitz O, Rosental B, Rosenberg LA, Navarro-Sanchez ME, Jivov S, Zilka A, Gershoni-Yahalom O, Brient-Litzler E, Bedouelle H, Ho JW, Campbell KS, Rager-Zisman B, Desprès P, Porgador A. (2009). NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol. 183:2610-21.

Coffey LL, Mertens E, Brehin AC, Fernandez-Garcia MD, Amara A, Desprès P, Sakuntabhai A. (2009). Human genetic determinants of dengue virus susceptibility. Microbes Infect.11:143-56. Review.

Bréhin AC, Casadémont I, Frenkiel MP, Julier C, Sakuntabhai A, Desprès P. (2009). The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus. Virology 384:216-22.

Pardigon N. (2009). The biology of chikungunya: a brief review of what we still do not know. Pathol Biol. 57:127-32. Review

 
 

Coutant F, Frenkiel MP, Desprès P, Charneau P. (2008). Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine. PLoS One: e3973. 

Kwan WH, Navarro-Sanchez EM, Dumortier H, Decossas M, Vachon H, dos Santos FB, Fridman HW, Rey FA, Harris E, Desprès P, Mueller CG. (2008). Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth. PLoS Negl Trop Dis.: e311.

Ozden S, Lucas-Hourani M, Ceccaldi PE, Basak A, Valentine M, Benjannet S, Hamelin J, Jacob Y, Mamchaoui K, Mouly V, Desprès P, Gessain A, Butler-Browne G, Chrétien M, Tangy F, Vidalain PO, Seidah NG. (2008). Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J Biol Chem. 283: 21899-908.

Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. (2008). A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. :e29.

Bréhin AC, Rubrecht L, Navarro-Sanchez ME, Maréchal V, Frenkiel MP, Lapalud P, Laune D, Sall AA, Desprès P. (2008). Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein. Virology 371:185-95.

 

Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Février M, Bedouelle H, Schwartz O, Desprès P, Tangy F. (2007). Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus. PLoS Negl Trop Dis.: e96.

Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I, Desprès P, Failloux AB. (2007). Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus.PLoS One :e1168.

Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saïb A, Rey FA, Arenzana-Seisdedos F, Desprès P, Michault A, Albert ML, Schwartz O. (2007). Characterization of reemerging chikungunya virus. PLoS Pathog. :e89.

Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, Desprès P, Gessain A, Ceccaldi PE. (2007). Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One :e527.